News Gedeon Richter LUXEMBOURG S.E.

Stocks

CHWGR

US3684672054

Pharmaceuticals

End-of-day quote LUXEMBOURG S.E. 11/11/2026			5-day change	1st Jan Change
39.40 ^USD	-1.01%		-1.50%	+30.46%

11-10	Gedeon Richter PLC Reports Earnings Results for the Nine Months Ended September 30, 2026	CI
10-14	Gedeon Richter Plc. Receives Fda Submission Acceptance of New Drug Application for Fylrevy® in the U.S	CI

All News

Mentions Relevance

f8818b82dd09779bec14471cc.-LLUNTb3vOwB62Re5m9p3niUHOAkODKOmjsTbRZs_wY.voCCQVrOzY1rrCUplxo-iQLlUL9LdV3C_Gh9QHlUk1WV8JZWQK3FtEamFw

11-10	Gedeon Richter PLC Reports Earnings Results for the Nine Months Ended September 30, 2026	CI
11-10	Gedeon Richter : Richter publishes Q1-Q3 2026 results	PU
10-14	Gedeon Richter : Richter receives FDA Submission Acceptance of New Drug Application for FYLREVY in the U.S.	PU
10-14	Gedeon Richter Plc. Receives Fda Submission Acceptance of New Drug Application for Fylrevy® in the U.S	CI
08-11	Gedeon Richter PLC, Q2 2026 Earnings Call, Aug 07, 2026
08-07	Gedeon Richter PLC Reports Earnings Results for the Half Year Ended June 30, 2026	CI
08-07	Gedeon Richter : Richter publishes Q2/H1 2026 results	PU
08-06	Gedeon Richter : Richter and Adalvo Expand Global Co-Development Partnership in Tirzepatide Across Diabetes and Obesity Care	PU
08-06	Gedeon Richter plc and Adalvo Expand Global Co-Development Partnership in Tirzepatide Across Diabetes and Obesity Care	CI
06-29	Gedeon Richter plc announces Resignation of Péter Cserháti as Member of the Board of Directors, with Effect from 1 July 2026	CI
06-10	Gedeon Richter : Richter and Hetero Announce Global Cooperation for the Development and Commercialization of Semaglutide Injection (Generic of Ozempic®)	PU
06-10	Gedeon Richter Plc. and Hetero Labs Ltd. Announce Global Collaboration Agreement for Joint Development, Registration, and Commercialization of Semaglutide Injection	CI
05-29	Gedeon Richter PLC Approves Dividend for the Financial Year 2025	CI
05-27	Hungary's Richter and Acrux agree to license transdermal estradiol spray for Australia	RE
05-27	Gedeon Richter : Richter and Acrux agree to license Lenzetto® for Australia	PU
05-16	Gedeon Richter PLC, Q1 2026 Earnings Call, May 12, 2026
05-14	Gedeon Richter : Transactions with Treasury Shares	PU
05-12	Gedeon Richter PLC Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
05-12	Gedeon Richter : Extraordinary Information	PU
05-12	Hungary's Richter says 2026 guidance fully reiterated high-single-digit growth in revenues and clean EBIT (at constant exchange rates)	RE
05-12	Gedeon Richter : Interim management statement	PU
05-12	Gedeon Richter : RichterIRpresentation May 2026	PU
05-12	Gedeon Richter : PresentationQ12026	PU
05-12	Gedeon Richter : Richter publishes Q1 2026 results	PU
05-12	Gedeon Richter : Earnings presentation Q1 2026 (PresentationQ12026)	PU